Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
     
Company Main View
  Name: Octagon Capital Advisors LP
  City: NEW YORK
  State: NY
  Zip: 10065
   
Achive data
  View Filing Period:
  
 
Portfolio Summary View Filing
  Filing Report Date : 2023-12-31
  Total Value : $624,987,000
  Total Value Change : $56,941,000
  Securities Held Change : -2
   
All Securities Held : 33
  New Positions : 10
  Closed Positions : 13
  Increased Positions : 6
  Unchanged Positions : 5
  Decreased Positions : 12

                  Consumer Discretionary Consumer Staples Financials Health Care Industrials Information Technology Basic Materials Conglomerates Energy Utilities
 Download  
 
    Free Registration Required For Full Results

    
Holdings Found : 12     View All Holdings Currently Viewing:  Decreased Positions     Page 1 of 1
     Menu
 Ticker Company Name Position
Rank		 New/Closed
Postion
Last
Close
     Value Shares Held
% of
Portfolio
Value
Change
Change In
Shares Held
    % of Company    Industry
   (APLS)1 Year Chart         APLS Apellis Pharmaceuticals Inc 1 - $41.31 $168,026,000 2,806,980 26.88% 48,961,000 -323,020 2.452    N/A
   (CBAY)1 Year Chart         CBAY Cymabay Therapeutics, Inc. 2 - $32.48 $63,154,000 2,673,750 10.1% 17,324,000 -400,000 2.822    N/A
   (RCUS)1 Year Chart         RCUS Arcus Biosciences Inc 5 - $16.90 $35,679,000 1,868,000 5.71% 353,000 -100,000 2.877    N/A
   (BBIO)1 Year Chart         BBIO Bridgebio Pharma, Inc. 6 - $30.09 $28,534,000 706,800 4.57% 2,912,000 -264,839 0.444    N/A
   (CLDX)1 Year Chart         CLDX Celldex Therapeutics Inc 7 - $38.21 $28,060,000 707,526 4.49% 7,148,000 -52,372 1.351    Diagnostic Substances
   (ROIV)1 Year Chart         ROIV Roivant Sciences Ltd. 8 - $11.23 $28,008,000 2,494,000 4.48% -22,999,000 -1,873,000 0.36    N/A
   (ANTX)1 Year Chart         ANTX An2 Therapeutics Ord Shs 12 - $2.27 $13,617,000 664,575 2.18% -334,000 -203,000 3.424    N/A
   (VRDN)1 Year Chart         VRDN Viridian Therapeutics Ors Shs 13 - $13.45 $13,504,000 620,000 2.16% -2,866,000 -447,143 1.368    N/A
   (AVTE)1 Year Chart         AVTE Aerovate Therapeutics, Inc. 18 - $0.00 $9,135,000 403,685 1.46% 2,386,000 -93,685 1.523    N/A
   (RPHM)1 Year Chart         RPHM Reneo Pharmaceuticals, Inc. 24 - $1.75 $3,600,000 2,250,000 0.58% -13,761,000 -29,870 9.263    N/A
   (INZY)1 Year Chart         INZY Inozyme Pharma, Inc. 28 - $0.00 $1,704,000 400,000 0.27% -3,756,000 -900,000 0.648    N/A
   (XLO)1 Year Chart         XLO Xilio Therapeutics, Inc. 30 - $0.00 $982,000 1,785,000 0.16% -3,910,000 -533,500 6.693    N/A
      12 Records Found
  1    
Page 1 of 1
Free Registration Required For Full Results

  
    
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us